Скачать или смотреть Antidiabetic drugs pharmacology, SGLT 2 inhibitors pharmacology, clinical pharmacology diabetes

💊 Sodium-glucose co-transporter 2 inhibitors also known as SGLT-2 inhibitors are a class of oral antidiabetic agents that reduce blood glucose levels by promoting the excretion of glucose in the urine. They primarily act in the proximal renal tubules to block glucose reabsorption, leading to glucosuria.

✅ SGLT-2 inhibitors (e.g., empagliflozin, dapagliflozin, canagliflozin) lower blood glucose by increasing glucose excretion in the urine.
✅ Provide cardiovascular and renal protection beyond glucose control.
✅ Reduce weight and blood pressure via osmotic diuresis.
✅ Common side effects: Genital and urinary tract infections, dehydration, hypotension.
✅ Rare but serious risks: Euglycemic diabetic ketoacidosis (DKA), lower limb amputations (with canagliflozin).
✅ Should not be used in eGFR less than 30 mL/min (except dapagliflozin for CKD less than 25 mL/min).
✅ Should be stopped before surgery to reduce DKA risk.
#sglt2 #diabetes #antidiabetic #pharamacologylectures #clinicalpharmacology

SGLT-2 inhibitors, diabetes, antidiabetic medications, antidiabetic rugs, antidiabetic drugs pharmacology, antidiabetic drugs osmosis, antidiabetic drugs ninja nerd, clinical pharmacology lectures diabetes, clinical pharmacology diabetes, diabetic drugs pharmacology, diabetic drugs pharmacology nursing, diabetes drugs pharmacology, clinical pharmacology lectures, clinical pearls diabetes, pharmacology lecture nursing, pharmacology made easy, SGLT-2 inhibitors pharmacology, SGLT-2 inhibitors clinical pharmacology, SGLT-2 inhibitors clinical pearls, clinical pharmacology made ridiculously simple, clinical pharmacology made simple

Chapters:
0:00 - SGLT-2 inhibitors pharmacology
0:23 - SGLT-2 inhibitors clinical pharmacology
0:31 - SGLT-2 inhibitors and DKA risk
1:01 - SGLT-2 inhibitors and cardiovascular benefits
1:29 - SGLT-2 inhibitors and genital infections
1:49 - SGLT-2 inhibitors and weight loss
2:06 - SGLT-2 inhibitors and renal impairment
2:27 - SGLT-2 inhibitors summary

🎯 𝗖𝗼𝗻𝗻𝗲𝗰𝘁 𝘄𝗶𝘁𝗵 𝗺𝗲 𝗼𝗻 𝘃𝗮𝗿𝗶𝗼𝘂𝘀 𝘀𝗼𝗰𝗶𝗮𝗹 𝗺𝗲𝗱𝗶𝗮 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺𝘀 𝘁𝗼 𝗲𝘅𝗽𝗹𝗼𝗿𝗲 𝗺𝗼𝗿𝗲 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝗳𝘂𝗹 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗽𝗲𝗮𝗿𝗹𝘀 𝗮𝗯𝗼𝘂𝘁 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝘆 𝗮𝗻𝗱 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲:
YouTube👉🏼: https://www.youtube.com/channel/pharm...
Instagram👉🏼:   / pharmacybyasim  
Twitter👉🏼:   / pharmed0929  
Facebook: https://www.facebook.com/profile.php?...
Buy me a coffee👉🏼: https://www.buymeacoffee.com/pharmacy...

🎯 𝗬𝗼𝘂 𝗰𝗮𝗻 𝗮𝗹𝘀𝗼 𝗷𝗼𝗶𝗻 𝗺𝘆 𝗪𝗵𝗮𝘁𝘀𝗔𝗽𝗽 𝗮𝗻𝗱 𝗧𝗲𝗹𝗲𝗴𝗿𝗮𝗺 𝗴𝗿𝗼𝘂𝗽𝘀 𝗳𝗼𝗿 𝗱𝗮𝗶𝗹𝘆 𝘂𝗽𝗱𝗮𝘁𝗲𝘀 𝗮𝗻𝗱 𝘃𝗮𝗹𝘂𝗮𝗯𝗹𝗲 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝗹𝗼𝗴𝘆 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀:
WhatsApp: https://chat.whatsapp.com/LYSaMZBsutA...
Telegram: https://t.me/+kjJ4_Cg4CMc5MDY0

☑️ 𝙁𝙤𝙧 𝙖𝙣𝙮 𝙌𝙪𝙚𝙧𝙞𝙚𝙨 𝙖𝙣𝙙 𝙎𝙪𝙜𝙜𝙚𝙨𝙩𝙞𝙤𝙣𝙨 𝙀𝙢𝙖𝙞𝙡 𝙤𝙣: [email protected]

𝗗𝗶𝘀𝗰𝗹𝗮𝗶𝗺𝗲𝗿:
"Content is For Informational & Education Purpose Only, Creamed From Various Authentic Books of Pharmacy & Medicine. The Video Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition."